FIELD: medicine.
SUBSTANCE: invention relates to the treatment of infectious diseases, and can be used to vaccinate immuno-compromised subjects against influenza. Use of the invention includes the intranasal administration of a vaccine comprising a composition comprising one or more non-living influenza virus antigens selected from the group consisting of an antigen of a whole inactivated virus, a split virus, a subunit antigen of the influenza virus and recombinant antigens, and an adjuvant comprising one or more carboxylic acids, an aqueous medium and one or more monoglycerides.
EFFECT: use of the invention makes it possible to reduce the release and the spread of the virus by decreasing the virus titer and inducing a high immune response.
15 cl, 5 tbl, 5 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE COMPOSITION FOR NON-IMMUNISED INDIVIDUALS | 2013 |
|
RU2661407C2 |
| MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION | 2004 |
|
RU2390351C2 |
| FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs) | 2006 |
|
RU2483751C2 |
| COMPOSITIONS FOR TREATING AND PREVENTING COMPLEX OF RESPIRATORY DISEASES IN DOGS | 2012 |
|
RU2553222C2 |
| COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1 | 2013 |
|
RU2639551C2 |
| INFLUENZA VACCINE | 2011 |
|
RU2583297C2 |
| IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica | 2012 |
|
RU2554480C2 |
| H1N1 INFLUENZA VIRUS ANTIGENS WITH WIDE SPECTRUM OF ACTIVITY, OPTIMIZED USING COMPUTER TOOLS | 2012 |
|
RU2612900C2 |
| VACCINES AND METHODS OF TREATING CANINE INFLUENZA | 2006 |
|
RU2396976C2 |
| METHOD TO APPLY MODIFIED FLU VIRUS | 2006 |
|
RU2480480C2 |
